PubRank

G Corneo

Author PubWeight™ 40.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Roots of clinical resistance to STI-571 cancer therapy. Science 2001 9.78
2 Mitochondrial DNA in yeast and some mammalian species. Science 1966 2.53
3 Isolation and characterization of mouse and guinea pig satellite deoxyribonucleic acids. Biochemistry 1968 2.19
4 Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571. J Natl Cancer Inst 2000 2.06
5 Location of satellite and homogeneous DNA sequences on human chromosomes. Nat New Biol 1971 1.54
6 Renaturation of calf thymus satellite DNA. J Mol Biol 1966 1.54
7 Renaturation properties and localization in heterochromatin of human satellite DNA's. Biochim Biophys Acta 1971 1.39
8 Repeated sequences in human DNA. J Mol Biol 1970 1.32
9 The chromosomal location of human satellite DNA 3. Chromosoma 1973 1.08
10 Different satellite deoxyribonucleic acids of guinea pig and ox. Biochemistry 1970 1.02
11 Isolation of the complementary strands of a human satellite DNA. J Mol Biol 1968 1.00
12 A satellite DNA isolated from human tissues. J Mol Biol 1967 0.98
13 Human mitochondrial DNA. J Mol Biol 1968 0.96
14 The chromosomal localisation of human satellite DNA I. Chromosoma 1974 0.88
15 Incidence and outcome of pneumonia in patients with acute leukemia receiving first induction therapy with anthracycline-containing regimens. Haematologica 2000 0.88
16 Elution of human satellite DNAs on a methylated albumin kieselguhr chromatographic column: isolation of satellite DNA. IV. Biochim Biophys Acta 1972 0.88
17 Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups. Hematol J 2001 0.86
18 Linkage in human heterochromatin between highly divergent Sau3A repeats and a new family of repeated DNA sequences (HaeIII family). J Mol Biol 1989 0.83
19 The organization of DNA sequences in the mouse genome. Chromosoma 1977 0.81
20 Molecular organization and chromosomal location of human GC-rich heterochromatic blocks. Gene 1993 0.80
21 Human T-cell lymphoblastic lymphoma expressing the T-cell receptor gamma/delta established in immune-deficient (bg/nu/xid) mice. Leukemia 1993 0.79
22 Amikacin and ceftazidime as empirical antibiotic therapy in severely neutropenic patients: analysis of prognostic factors. Support Care Cancer 1994 0.78
23 Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study. Haematologica 1999 0.78
24 Increased susceptibility to lymphokine activated killer (LAK) lysis of relapsing vs. newly diagnosed acute leukemic cells without changes in drug resistance or in the expression of adhesion molecules. Ann Oncol 1992 0.78
25 Thrombotic complications in acute promyelocytic leukemia during all-trans-retinoic acid therapy. Acta Haematol 1997 0.78
26 Acute leukaemia following cisplatin for ovarian cancer. Haematologica 1987 0.78
27 Satellite DNAs in eukaryotes: a non-adaptive mechanism of speciation which originated with sexual reproduction? Experientia 1978 0.77
28 High dose intravenous immunoglobulin (IVIgG) in Evans' syndrome. Allergol Immunopathol (Madr) 1992 0.76
29 Early detection of relapse in acute non-lymphoblastic leukaemia patients by cancer procoagulant assay. Eur J Cancer 1991 0.76
30 Imatinib dose increase up to 1200 mg daily can induce new durable complete cytogenetic remissions in relapsed Ph+ chronic myeloid leukemia patients. Leukemia 2005 0.76
31 Intravenous infusions of gammaglobulin in adults with chronic refractory immune thrombocytopenic purpura. Blood 1989 0.75
32 Anthracycline drugs and MDR expression in human leukemia. Cytotechnology 1996 0.75
33 The organization of repeated DNA sequences in the human genome. Chromosoma 1976 0.75
34 Detection of human chromosomes in somatic cell hybrids by PCR analysis. Cytogenet Cell Genet 1993 0.75
35 L-asparaginase in acute lymphoblastic leukemia treatment: the role of human antithrombin III concentrates in regulating the prothrombotic state induced by therapy. Acta Haematol 1995 0.75
36 Presence of a satellite DNA in normal and leukemic human tissues. Acta Haematol 1968 0.75
37 Elution of mammalian nuclearsatellite DNA's on methylated albumin kieselguhr and hydroxyapatite chromatographic columns. Biochim Biophys Acta 1970 0.75
38 Aplastic anemia: some clinical and laboratory aspects and an evaluation of the androgen-glucocorticoid treatment. Acta Haematol 1971 0.75
39 [Recent findings on the role of oncogenes in neoplasms]. Recenti Prog Med 1989 0.75
40 [Chromosome study in a case of malignant reticulosis]. Haematologica 1973 0.75
41 Increased amplification of abl oncogene in K562 cells after passage in nude mice. Acta Haematol 1990 0.75
42 Human leukemic intermediate DNA components. Acta Haematol 1975 0.75
43 [Etiopathogenetic, clinical and therapeutic aspects of involutive myelopathies]. Recenti Prog Med 1973 0.75
44 Satellite DNA sequences and reproductive isolation in the Drosophila willistoni group. Experientia 1980 0.75
45 Therapy-related acute promyelocytic leukemia. Leukemia 1993 0.75
46 Cloning of a repeat sequence from human DNA which contains a BamHI site. Biochim Biophys Acta 1985 0.75
47 Restriction enzyme studies on human highly repeated DNAs. Experientia 1982 0.75
48 Antifibrinolytic therapy in acute promyelocytic leukemia. Acta Haematol 1989 0.75
49 Molecular basis of chromosome banding. I. The effect of mouse DNA fractions on two fluorescent dyes in vitro. Chromosoma 1975 0.75
50 Lymphocyte subsets in patients with idiopathic thrombocytopenic purpura during high-dose gamma globulin therapy. Allergol Immunopathol (Madr) 1992 0.75
51 Role of granulocyte colony-stimulating factor in relapsed/resistant intermediate and high-grade non-Hodgkin's lymphoma patients treated with the E-SHAP regimen. Tumori 1995 0.75
52 Idarubicin in the initial treatment of adults with acute lymphoblastic leukemia: the effect of drug schedule on outcome. Leuk Lymphoma 1993 0.75
53 A case of acute lymphoblastic leukemia in an anti-HIV positive patient. Allergol Immunopathol (Madr) 1992 0.75
54 Induction-consolidation with an idarubicin-containing regimen, unpurged marrow autograft, and post-graft chemotherapy in adult acute lymphoblastic leukaemia. Br J Haematol 1999 0.75
55 Defibrotide in recurrent thrombotic thrombocytopenic purpura. Clin Appl Thromb Hemost 2000 0.75
56 Bleeding time and antiplatelet agents in normal volunteers. Int J Clin Lab Res 1992 0.75
57 Fractionation of calf thymus deoxyribonucleic acid by density-gradient centrifugation. Biochim Biophys Acta 1965 0.75
58 [Clinical course of refractory anemia. Study of a case series of 56 patients]. Clin Ter 1991 0.75
59 Alpha interferon as initial treatment of essential thrombocythemia. Analysis after two years of follow-up. Tumori 1996 0.75
60 Hybridization of mouse leukemia virus c-DNA to mouse repeated DNA sequences. Acta Haematol 1975 0.75
61 [Clinical and therapeutic aspects of polycythemia vera]. Recenti Prog Med 1978 0.75
62 Non-Hodgkin's lymphoma of the elderly. Prognostic factors and outcome. Recenti Prog Med 1991 0.75
63 Heterogeneity of base composition of DNA extracted from human leukaemic leucocytes. Eur J Cancer 1966 0.75
64 Repeated sequences in human leukemic DNA. Acta Haematol 1971 0.75
65 Repeated nucleotide sequences in human main band DNA. Biochim Biophys Acta 1980 0.75
66 Chromosome 7 monosomy and deletions in myeloproliferative diseases. Leuk Res 2001 0.75
67 [An international Balint encounter]. Z Krankenpfl 1976 0.75
68 Antiphospholipid antibodies and splenic thrombosis in a patient with idiopathic myelofibrosis (antiphospholipid antibodies and thrombosis). Haematologica 1993 0.75
69 Acute lymphoblastic leukemia (ALL) and cancer procoagulant activity. Haematologica 1992 0.75
70 Granulocyte colony-stimulating factor (G-CSF, filgrastim) after or during an intensive remission induction therapy for adult acute lymphoblastic leukaemia: effects, role of patient pretreatment characteristics, and costs. Leuk Lymphoma 1997 0.75
71 Translocation of oncogene c-sis from chromosome 22 to chromosome 17 in a human myelogenous leukemia cell line. Acta Haematol 1987 0.75
72 Localization of human satellite DNA I. Cytogenet Cell Genet 1975 0.75
73 Some clinical aspects of myelofibrosis: a study of 21 patients. Haematologica 1977 0.75
74 Homology between cellular repeated nucleotide sequences and a murine leukemia viral genome. Tumori 1978 0.75
75 Restriction enzyme studies on highly repeated DNAs of human leukemic leucocytes. Haematologica 1982 0.75
76 Could bovine leukemia virus be a possible agent of some human lymphatic leukemias? Acta Haematol 1984 0.75
77 Localization of human satellite DNA I. Birth Defects Orig Artic Ser 1975 0.75
78 [Non-Hodgkin's lymphomas: staging and therapy]. Clin Ter 1989 0.75
79 [Oncogenes and malignant hemopathies]. Recenti Prog Med 1989 0.75
80 Surgery and chemotherapy in the treatment of gastric non-Hodgkin's lymphoma. Recenti Prog Med 1990 0.75
81 Intracellular localization and hybridization studies of a human satellite DNA. Biochim Biophys Acta 1968 0.75